CN

Constant Innovation For Life

Chipscreen Biosciences strives to make
breakthrough therapies accessible and
affordable for patients around the world.

Corporate Promotion Video

News & Reports
Reports
2015.05.22
《CCTV News》Lu Xianping: Producing Affordable Life-Saving Medicines for the Public
2017.07.31
《Economic Half Hour》Pay attention to major technological innovations: domestically produced anti-cancer drugs entering medical insurance
2021.04.23
Corporate Video
News
Core Technologies

Leveraging its AI + chemical genomics technology platform, the Company has built an integrated R&D system spanning novel drug molecule discovery, early-stage evaluation, and clinical development. This platform enables the Company to develop innovative, mechanism-of-action therapies with differentiated clinical profiles in to address significant unmet medical needs.

Learn MoreLearn More
Core Technologies
Scientific Committee
R&D System
Drug Lifecycle Management
800+
Invention patents applied
5
New molecular entity
projects in development
2
Approved marketed products
11
Products in clinical
development stage
Innovative Product Pipelines
Committed to developing globally first-in-class and best-in-class original innovative drugs
The company has two innovative drugs with multiple indications marketed globally and has deployed multiple R&D projects with differentiated advantages and global competitiveness in four major areas: malignant tumors, metabolic diseases, autoimmune diseases, and neurodegenerative diseases.
Learn MoreLearn More